Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

European Nicotinamide Diabetes Intervention Trial Group

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

European Nicotinamide Diabetes Intervention Trial Group

Research output: Contribution to journal › Article › Scientific › peer-review

103 Citations (Scopus)

Original language	English
Pages (from-to)	881-890
Journal	Diabetologia
Volume	49
Publication status	Published - 2006
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://pubmed.ncbi.nlm.nih.gov/16514546

Cite this

@article{3df50629a5ef4e03b5bfbbbb02ab71c3,

title = "Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk",

author = "\{European Nicotinamide Diabetes Intervention Trial Group\} and PJ Bingley and EA Gale and M Knip",

year = "2006",

language = "English",

volume = "49",

pages = "881--890",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Verlag",

}

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. / European Nicotinamide Diabetes Intervention Trial Group.
In: Diabetologia, Vol. 49, 2006, p. 881-890.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

AU - European Nicotinamide Diabetes Intervention Trial Group

AU - Bingley, PJ

AU - Gale, EA

AU - Knip, M

PY - 2006

Y1 - 2006

M3 - Article

SN - 0012-186X

VL - 49

SP - 881

EP - 890

JO - Diabetologia

JF - Diabetologia

ER -